Cargando…
Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data
PURPOSE: Triple-positive breast cancer is defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) positivity. Several systemic breast cancer therapies target hormonal and HER2 responsiveness. We compared clinical outcomes of triple-positive disease wi...
Autores principales: | You, Sun Hyong, Chae, Byung Joo, Eom, Yong Hwa, Yoo, Tae-Kyung, Kim, Yong-seok, Kim, Jeong Soo, Park, Woo-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310716/ https://www.ncbi.nlm.nih.gov/pubmed/30607163 http://dx.doi.org/10.4048/jbc.2018.21.e53 |
Ejemplares similares
-
Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
por: Park, Hyung Seok, et al.
Publicado: (2012) -
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
por: Eom, Yong Hwa, et al.
Publicado: (2016) -
The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database
por: Min, Sun Young, et al.
Publicado: (2016) -
Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society
por: Kim, Hyung Suk, et al.
Publicado: (2019) -
Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)